Alzamend Neuro

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alzamend Neuro and other ETFs, options, and stocks.

About ALZN

Alzamend Neuro, Inc. is a preclinical stage biopharmaceutical company, which engages in the manufacture of pharmaceutical products. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders. 

CEO
Stephan Jackman
CEOStephan Jackman
Employees
4
Employees4
Headquarters
Atlanta, Georgia
HeadquartersAtlanta, Georgia
Founded
2016
Founded2016
Employees
4
Employees4

ALZN Key Statistics

Market cap
103.60M
Market cap103.60M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
952.49K
Average volume952.49K
High today
$1.18
High today$1.18
Low today
$1.06
Low today$1.06
Open price
$1.15
Open price$1.15
Volume
367.26K
Volume367.26K
52 Week high
$3.57
52 Week high$3.57
52 Week low
$0.8005
52 Week low$0.8005

ALZN Earnings

-$0.07
-$0.05
-$0.02
$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Estimated
-$0.07 per share
Estimated-$0.07 per share
Actual
-$0.03 per share
Actual-$0.03 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.